Both are currently Food and Drug Administration (FDA) approved for adults with different indications for use
In the overall cohort, monocyte-to-lymphocyte ratio (MoLR) and neutrophil-to-lymphocyte ratio (NLR) had the best discriminative ability for 3-month outcome (AUC 0.65 and 0.64, respectively), with significant associations maintained in multivariable analysis adjusted for age, sex, onset-to-door delay, acute treatment, large-vessel occlusion, ASPECTS, NIHSS, active cancer, acute CRP, pre-stroke mRS (MoLR: aOR 1.01, 95%CI 1.001.01, p 2 group, all with available thrombi extracted during endovascular thrombectomy (EVT)
Caltabiano et al., 2020)
To model hospital outlier payments for the CY 2026 OPPS/ASC proposed rule, we applied the overall CCRs from the April 2025 OPSF after adjustment (using the proposed CCR inflation adjustment factor of 0.970113 to approximate CY 2026 CCRs) to charges on CY 2024 claims that were adjusted (using the proposed charge inflation factor of 1.1118 to approximate CY 2026 charges)